Literature DB >> 2358801

Investigations on auto-antibodies in Alzheimer's and Parkinson's diseases, using defined neuronal cultures.

A Dahlström1, A Wigander, K Lundmark, C G Gottfries, P M Carvey, A McRae.   

Abstract

In immunocytochemical studies, the CSF from Parkinson disease (PD) patients and from Alzheimer disease (AD) patients were investigated for the presence of neuron specific antibodies using dopaminergic and cholinergic neuronal cultures from embryonic rat brain, respectively. Dopamine containing cell bodies were labelled by Parkinsonian CSF-IgG, while cholinergic neurons, identified with a-NGF-receptor antibodies, were recognized by CSF from AD-patients. The CSF from PD-patients was investigated after autologous adrenal transplantation. CSF was removed 7 d, 5 months and 1 year after operation. When added to 18 d neuronal cultures for 3 d, the 7 d CSF caused neuronal cell and a glial reaction. The 4 months CSF caused cell death, but markedly less than the 7 d CSF. One year after transplantation the CSF had no toxic effects; these cultures were similar to control cultures. It is concluded that CSF from PD patients may contain aggressive IgG-species specific for DA neurons, and that the amount of such antibodies decrease after adrenal transplant operations. It is suggested that neurodegenerative diseases may become aggravated by autoimmune reactions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2358801     DOI: 10.1007/978-3-7091-9050-0_19

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  8 in total

1.  Treatment for Helicobacter pylori infection and risk of Parkinson's disease in Denmark.

Authors:  H H Nielsen; J Qiu; S Friis; L Wermuth; B Ritz
Journal:  Eur J Neurol       Date:  2012-01-17       Impact factor: 6.089

Review 2.  Inflammation and adaptive immunity in Parkinson's disease.

Authors:  R Lee Mosley; Jessica A Hutter-Saunders; David K Stone; Howard E Gendelman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 3.  Involvement of Fc receptors in disorders of the central nervous system.

Authors:  Eitan Okun; Mark P Mattson; Thiruma V Arumugam
Journal:  Neuromolecular Med       Date:  2009-10-21       Impact factor: 3.843

4.  Immunocytochemical detection of anti-hippocampal antibodies in Alzheimer's disease and normal cerebrospinal fluid.

Authors:  D A Loeffler; P L Juneau; H U Nguyen; D Najman; N Pomara; P A LeWitt
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

5.  Serum antibodies from Parkinson's disease patients react with neuronal membrane proteins from a mouse dopaminergic cell line and affect its dopamine expression.

Authors:  Victor C Huber; Tapan Mondal; Stewart A Factor; Richard F Seegal; David A Lawrence
Journal:  J Neuroinflammation       Date:  2006-01-20       Impact factor: 8.322

Review 6.  Peripheral aetiopathogenic drivers and mediators of Parkinson's disease and co-morbidities: role of gastrointestinal microbiota.

Authors:  Sylvia M Dobbs; R John Dobbs; Clive Weller; André Charlett; Aisha Augustin; David Taylor; Mohammad A A Ibrahim; Ingvar Bjarnason
Journal:  J Neurovirol       Date:  2015-06-20       Impact factor: 2.643

Review 7.  Helicobacter pylori infection is associated with a poor response to levodopa in patients with Parkinson's disease: a systematic review and meta-analysis.

Authors:  Rui Zhong; Qingling Chen; Xinyue Zhang; Mengmeng Li; Weihong Lin
Journal:  J Neurol       Date:  2021-02-22       Impact factor: 4.849

Review 8.  Helicobacter hypothesis for idiopathic parkinsonism: before and beyond.

Authors:  R John Dobbs; Sylvia M Dobbs; Clive Weller; André Charlett; Ingvar T Bjarnason; Alan Curry; David S Ellis; Mohammad A A Ibrahim; Maria V McCrossan; John O'Donohue; Robert J Owen; Norman L Oxlade; Ashley B Price; Jeremy D Sanderson; Malur Sudhanva; John Williams
Journal:  Helicobacter       Date:  2008-10       Impact factor: 5.753

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.